-
Stutts was commissioned by executives at Genentech to lead a task force looking into why clinical trials often aren't diverse.
FORBES: Genentech To Increase Diversity In Clinical Trials
-
Faced with big questions, Stutts and her team wound up talking with Baylor and decided to hatch a project to get more answers.
FORBES
-
For instance, Stutts says, it's thought that African-American communities often have a deep-seated distrust of the medical establishment and of being experimental subjects.
FORBES: Genentech To Increase Diversity In Clinical Trials
-
"This should have been fixable, " says Stutts.
FORBES: Genentech To Increase Diversity In Clinical Trials
-
Mary Stutts , a senior director in corporate communications at Genentech, tells the story of one woman, an African-American single mother, who was one of the best responders to Tarceva, the lung cancer treatment Genentech developed with Melville, N.
FORBES: Genentech To Increase Diversity In Clinical Trials